SCHEMBL5240239

SCHEMBL5240239

COC(=O)Oc1sccc1NC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 1/20 0.41
PTK2 Q05397 1/20 0.40
TSHR P16473 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
RAB9A P51151 1/20 0.38
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4785507 0.82 METAP1 (0.44) MAPTALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL4608245 0.82 CYP1A2 (0.48) ALDH1A1PKMHPGDSMN1; SMN2MEN1
SCHEMBL6100903 0.81 L3MBTL1 (0.37) MAPTALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL9050785 0.78 MAPK8 (0.64) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL4633510 0.77 KMT2A (0.65) MAPTALDH1A1NPC1TSHRHPGD
SCHEMBL3672729 0.77 KDM4E (0.37) MAPTALDH1A1NPC1PTK2TSHR
SCHEMBL10804734 0.77 HPGD (0.41) MAPTALDH1A1NPC1PKMHPGD
SCHEMBL4607918 0.75 KDM4E (0.36) MAPTALDH1A1NPC1PTK2HPGD
SCHEMBL14486887 0.75 MAPT (0.37) MAPTALDH1A1NPC1PKMHPGD
SCHEMBL9533816 0.75 KDM4E (0.36) MAPTALDH1A1NPC1PTK2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664058-B1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-14 EP disclosed
EP-1664058-A1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME Sanofi-Aventis Deutschland GmbH (DE) 2006-06-07 EP disclosed
EP-1513834-B1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME SANOFI AVENTIS DEUTSCHLAND (DE) 2006-03-15 EP disclosed
WO-2005026173-A1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-03-24 WO disclosed
EP-1513834-A1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME Aventis Pharma Deutschland GmbH (DE) 2005-03-16 EP disclosed
WO-2003101984-A1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed